RxDoctor Payments Data

Daniel Nardi

Medical · Fayetteville, NCNPI 1255971883

Payments from drug & device makers

$3,160in general payments, 2019–2025

Across 164 payments — averaging $19.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$479
  • AstraZeneca$406
  • Lilly USA, LLC$284
  • AbbVie$171
  • GSK$160
  • Merck$159
  • plus $2K from 32 others

What the payments were for

  • Food & beverage$2,99695%
  • Education$1645%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,160 in reported general payments places this provider in the 80th percentile of 878 medical providers in North Carolina.

See all medical providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide20$20,736
MounjaroTirzepatide11$14,403
JardianceEmpagliflozin13$13,865
SymbicortBudesonide/Formoterol Fumarate13$3,039
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav58$536
Azithromycin107$434
Albuterol Sulfate HfaAlbuterol Sulfate15$391
Doxycycline Hyclate46$346
Gabapentin27$321
Mupirocin40$299
Prednisone176$292
Fluconazole50$217
Omeprazole15$196
Diclofenac Sodium15$177
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen27$163

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$479$20,73620 claims
Lilly USA, LLCMounjaro$284$14,40311 claims
Boehringer IngelheimJardiance$116$13,86513 claims
AstraZenecaSymbicort$406$3,03913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 878 medical providers in North Carolina.

Other medical in Fayetteville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →